Notable deals in the pharmaceutical industry in the fourth quarter of 2016.
Drugs Today (Barc)
; 53(1): 75-82, 2017 Jan.
Article
in En
| MEDLINE
| ID: mdl-28387386
ABSTRACT
During the fourth quarter of 2016, Cortellis Competitive Intelligence had 889 new deals added as part of its ongoing coverage of pharmaceutical licensing activity. This was an increase on both the last quarter (865) but a decrease from the same quarter for the previous year (915). This article will focus on highlighting a number of the most valuable and notable deals forged during the quarter, as well as a selection of deals from some of the most prolific deal makers. An update on milestones, options and terminated deals of significance will also be presented, along with an early outlook on the next quarter's pharmaceutical licensing activity.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Research Support as Topic
/
Drugs, Investigational
/
Commerce
/
Drug Industry
/
Pharmaceutical Research
Limits:
Humans
Language:
En
Journal:
Drugs Today (Barc)
Journal subject:
MEDICINA OCUPACIONAL
/
SAUDE AMBIENTAL
Year:
2017
Document type:
Article
Affiliation country:
United kingdom